The stock market doesn't run on reason.....Results are sue in about 6 weeks, it will be a run up to it. I would expect quite a few 5-10% days coming and if their earnings report isn't too shabby it might lift off before the phase 3 results in March. Not to mention in and outs taking advantage.
They aren't going to release results in March. There is going to be an interim review which will remain blinded to the company and they will find out how many patients are needed to complete the trial. We actually won't see the results of the trial until probably the end of the year.